Vanderbilt Institute for Clinical and Translational Research (VICTR) Archive — Page 5 of 7

August 14, 2018

Medically underserved women in the Southeast rarely receive BRCA tests

Medically underserved women in the Southeast diagnosed with breast cancer or ovarian cancer missed out on genetic testing that could have helped them and their relatives make important decisions about their health, according to new research from Vanderbilt-Ingram Cancer Center.

By Tom Wilemon
April 19, 2018

VUMC drug repurposing initiative gaining momentum

Drug repurposing involves establishing an additional approved indication for a drug already at market.

By Paul Govern
Illustration of human intestinal tract
March 22, 2018

Grant bolsters study of potential new therapy for C. diff infection

According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis.

By Paul Govern
March 1, 2018

Study reveals safety signal from genes that mimic drugs

Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal Drug Safety by researchers at Vanderbilt University Medical Center.

By Paul Govern
February 8, 2018

Event showcases REDCap’s data management versatility

Fourteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has transformed clinical and translational studies around the globe.

By Bill Snyder
September 21, 2017

New lab formulary improves quality, cuts cost

An effort at Vanderbilt University Medical Center (VUMC) to enhance clinical decision making through cross-departmental collaboration and effective use of diagnostics has improved patient care and saved the institution more than $1 million in 2016, VUMC officials reported this week.

By Bill Snyder